• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

    71.28 +0.05 (+0.07%)
    Official Closing Price Updated: 4:15 PM EDT, Jun 13, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 12,839,952
    Open 68.57
    Bid (Size) 70.87 (4)
    Ask (Size) 70.94 (1)
    Prev. Close 71.23
    Today's Range 68.35 - 74.23
    52wk Range 22.89 - 91.45
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    TEMPUS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Tempus AI, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    TEM Investor Notice: Robbins LLP Reminds Shareholders of the Class Action Lawsuit Against Tempus AI, Inc. Class Action
    From Robbins LLP
    Via GlobeNewswire

    Performance

    YTD
    +108.1%
    +108.1%
    1 Month
    +10.0%
    +10.0%
    3 Month
    +51.1%
    +51.1%
    6 Month
    +73.9%
    +73.9%
    1 Year
    +77.1%
    +77.1%

    More News

    Read More
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Tempus Announces Collaboration with Northwestern University’s Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer’s Disease Research
    From Tempus AI, Inc.
    Via Business Wire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc. - TEM
    From Pomerantz LLP
    Via GlobeNewswire
    Cathie Wood Sharers Her Take On Chatbots And Robots Taking Human Jobs: 'We'll See More People Taking Risks'
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Why Shares of Tempus AI Are Jumping Higher This Week
    Via The Motley Fool
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc. - TEM
    From Pomerantz LLP
    Via GlobeNewswire
    Update! What Is Congress Trading So Far In 2025?
    Via MarketBeat
    TEMPUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Tempus AI, Inc. on Behalf of Tempus Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Why Tempus AI Stock Soared 15% Today
    Via The Motley Fool
    Topics Artificial Intelligence Stocks
    Exposures Artificial Intelligence US Equities
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tempus AI, Inc. - TEM
    From Pomerantz LLP
    Via GlobeNewswire
    TEM Investor News: If You Have Suffered Losses in Tempus AI, Inc. (NASDAQ: TEM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    Vera Therapeutics, Applied Digital, Kymera Therapeutics And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Tempus AI Stock Rockets After Introduction Of Liquid Biopsy Assay For Cancer Treatment Monitoring: Retail Hopes For A 20% Rally
    Via Stocktwits
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Tempus AI Stock Is Surging Today: What Investors Are Watching
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Tempus Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers
    From Tempus AI, Inc.
    Via Business Wire
    Introducing Tempus One in the EHR with Integrated Guidelines
    From Tempus AI, Inc.
    Via Business Wire
    Tempus Introduces Fuses, A Program Designed to Transform Therapeutic Research and Build the Largest Diagnostic Platform Using its Novel Foundation Model
    From Tempus AI, Inc.
    Via Business Wire
    Tempus AI Stock: Buy the Dip, or Is the Short-Seller Right?
    Via The Motley Fool
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Why Tempus AI Stock Plummeted This Week
    Via The Motley Fool
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Real-World Deployments Signal AI Healthcare Is Ready for Scale
    Via FinancialNewsMedia
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Tempus Announces 10 Abstracts Accepted for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting
    From Tempus AI, Inc.
    Via Business Wire
    Tempus: Short Seller Attack Brings Golden Opportunity Cathie Wood Was Waiting For
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Nvidia, Apple, Amazon, Tempus AI, Tesla: Why These 5 Stocks Are On Investors' Radars Today
    Via Benzinga
    Topics Artificial Intelligence Stocks
    Exposures Artificial Intelligence US Equities

    Frequently Asked Questions

    Is Tempus AI, Inc. - Class A Common Stock publicly traded?
    Yes, Tempus AI, Inc. - Class A Common Stock is publicly traded.
    What exchange does Tempus AI, Inc. - Class A Common Stock trade on?
    Tempus AI, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Tempus AI, Inc. - Class A Common Stock?
    The ticker symbol for Tempus AI, Inc. - Class A Common Stock is TEM on the Nasdaq Stock Market
    What is the current price of Tempus AI, Inc. - Class A Common Stock?
    The current price of Tempus AI, Inc. - Class A Common Stock is 71.28
    When was Tempus AI, Inc. - Class A Common Stock last traded?
    The last trade of Tempus AI, Inc. - Class A Common Stock was at 06/13/25 04:15 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.